Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "RAT"

9973 News Found

Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%
Clinical Trials | April 22, 2026

Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%

The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints


Lilavati Hospital expands into Gujarat with GIFT City facility, launches free health camp
Hospitals | April 21, 2026

Lilavati Hospital expands into Gujarat with GIFT City facility, launches free health camp

The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions


SRM International Hand Conclave 2026 spotlights innovation and collaboration in hand rehabilitation
Healthcare | April 20, 2026

SRM International Hand Conclave 2026 spotlights innovation and collaboration in hand rehabilitation

The conclave brought together over 1,000 delegates from across India and internationally


Aurobindo Pharma bags USFDA nod for Glycerol Phenylbutyrate Oral Liquid
Drug Approval | April 20, 2026

Aurobindo Pharma bags USFDA nod for Glycerol Phenylbutyrate Oral Liquid

The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics


Neuland Laboratories elevates Saradhi Bolli to Global Head of CDMO Business Development
People | April 20, 2026

Neuland Laboratories elevates Saradhi Bolli to Global Head of CDMO Business Development

Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services


NHA convenes Chintan Shivir to accelerate Ayushman Bharat schemes
Policy | April 18, 2026

NHA convenes Chintan Shivir to accelerate Ayushman Bharat schemes

Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM


Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development
Biopharma | April 17, 2026

Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development

Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines


Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
Drug Approval | April 17, 2026

Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection

Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions